PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ijmsMDPIhomeThis articleThis journalInstructions for authorsSubscribeIJMS
 
Int J Mol Sci. 2011; 12(12): 8661–8694.
Published online Nov 30, 2011. doi:  10.3390/ijms12128661
PMCID: PMC3257095
A Concise Review on Epigenetic Regulation: Insight into Molecular Mechanisms
Shahram Golbabapour,* Mahmood Ameen Abdulla, and Maryam Hajrezaei
Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia; E-Mails: ammeen/at/um.edu.my (M.A.A.); maryam_hajrezaie/at/yahoo.com (M.H.)
*Author to whom correspondence should be addressed; E-Mail: ugreenk/at/gmail.com; Tel.: +603-7967-6604; Fax: +603-7967-6600.
Received August 9, 2011; Revised November 7, 2011; Accepted November 10, 2011.
Epigenetic mechanisms are responsible for the regulation of transcription of imprinted genes and those that induce a totipotent state. Starting just after fertilization, DNA methylation pattern undergoes establishment, reestablishment and maintenance. These modifications are important for normal embryo and placental developments. Throughout life and passing to the next generation, epigenetic events establish, maintain, erase and reestablish. In the context of differentiated cell reprogramming, demethylation and activation of genes whose expressions contribute to the pluripotent state is the crux of the matter. In this review, firstly, regulatory epigenetic mechanisms related to somatic cell nuclear transfer (SCNT) reprogramming are discussed, followed by embryonic development, and placental epigenetic issues.
Keywords: epigenetic, pluripotency, SCNT, embryogenesis, gametogenesis, polycomb, methylation, histone modification
The transition from the differentiated somatic cell to the embryonic stage through somatic cell nuclear transfer (SCNT) requires activation energy to efficiently reprogram the resultant zygote to a proper pluripotent state [1,2]. SCNT is a tool to clone nuclear material into the enucleated cytoplasm of an unfertilized oocyte and thereby create genetically identical animals (Figure 1). SCNT not only benefits agricultural applications, but has the potential for great advances in the field of medicine. In addition, SCNT has paved the way to better understand the changes in cell differentiation and reprogramming. Despite many investigations that have been done by numerous laboratories, the efficiency (i.e., the ability to create a live born animal per nuclear transfer) by this technique is still below 5% and several abnormalities have been reported [3]. One of the main reasons for these abnormalities is the failure in reprogramming/remodeling of differentiated cells to the stage that will evolve to a normal neonate. In the other words, programs involved in differentiated cells should be replaced with totipotency to ensure nuclear cloning and production of healthy offspring. Gene regulatory pathways are the critical network that could redefine SCNT. Clones, on the other hand, have to change expression profiles to embryo-specific, global rearrangement of chromatin structure. As a result, the cloning study is a way to understand epigenetic mechanisms and reprogram differentiated nuclei. Epigenetic modifications in the donor cells remodel the gene expression profile to the extent that is similar to the normal embryo. However, the epigenetic mechanisms that are responsible for the transformation from a differentiated somatic cell into a pluripotent state remain mysterious. In this review, we explore the epigenetic regulatory events that occur during the gametogenesis, embryogenesis and placental development. The epigenetic modifications that modulate expression of genes and subsequent reprogramming of the somatic nucleus to pluripotent state are also briefly discussed. The purpose of review is to summarize effective epigenetic events that could increase efficiency of SCNT and to emphasize recent epigenetic findings. In this regards, we briefly look into transition techniques and highlight epigenetic modifications that happen during the nucleus reprogramming.
Figure 1
Figure 1
The schematic method used to create a cloned animal. A nucleus is taken from a somatic cell (nucleus donor animal) and injected into enucleated Oocyte (Oocyte donor animal). The zygotic cell begins dividing and the resultant blastocyst (embryo) transfers (more ...)
SCNT provides new insight into gene manipulation to achieve defined purposes. This technique is to reprogram the differentiated somatic cell to a pluripotent state by transferring the nucleus of a somatic cell into an enucleated oocyte and produce a zygote, which results in a live offspring. In mammals, genomes of differentiated cell have to reprogram to a totipotent state to establish SCNT during pre-implantation. Consequently, the development of a zygote initiates and follows with blastocyst and the subsequent embryonic stages. Cloned embryos derived from less differentiated cells (as nucleus donors), such as embryonic stem cells, show better implantation than those derived from more differentiated somatic cells probably due to minimum or no reprogramming requirement [4]. It was shown that the efficiency of bovine SCNT is relatively higher than the other experienced species (for see review [5]) and pregnancy in Bos taurus is very similar to that of human in terms of length and development.
Generation of induced pluripotent stem cell is to transport defined regulatory signals, influence the epigenetic state and change it to another state (plasticity) which emphasizes the mutual reliance between cell identity and epigenetic states [6,7]. This is, especially true during early embryo development and gametogenesis [1]. Pluripotent stem cells are driven from somatic cells that are introduced by specific reprogramming factors through either cell fusion or delivery of defined biochemical and/or chemical factors which are also categorized as a reprogramming approach. The fusion technique produces hybrid cells from differentiated somatic cells by nuclear reprogramming through the reactivation of embryo-specific genes, whose expressions are suppressed in somatic cells [8]. In 2006, a four-gene set was introduced to reprogram somatic cells to a pluripotent state [7]. Hybrid cells produced by fusion technique show a pluripotent state by expression of the pluripotent markers such as OCT4 [9]. Moreover, a number of other genes such as Nanong, Sox2, Lin28, Klf4, c-Myc and AID have been correlated to the pluripotent state of a cell. The expressions of these genes result in cell reprogramming [7,1013]. Based on these evidences, identification of embryo-specific genes is crucial to defining their expression profiles during embryogenesis, functions during different stages of embryogenesis and the development of placenta. These regulations, actually, are defined epigenetic regulation for which molecular signals modulate the modifications.
Several morphological abnormalities such as hydroallantois, placentomegaly, cardiomegaly, enlarged umbilical cord, abdominal ascites and placental dysfunctions [14,15], have been observed in the cloned offsprings. Large offspring syndrome (LOS) is a developmental disorder mostly seen in SCNT driven embryos. This syndrome in addition to the failure in the development of embryo and placenta and other abnormalities is attributed to inappropriate and/or inadequate somatic nuclear reprogramming events. Significant increase in genomic methylation in liver of cloned bovine fetuses is attributed to fetal overgrowth [16]. LOS and failure in the normal development of an embryo that are seen in cloned animals could be due to abnormal epigenetic patterns [17]. In fact, assisted reproductive techniques appear to be accompanied by several anomalies, especially in the second half of the gestation [14,1820].
Cells’ information is inherited to the next generation through genetic and epigenetic routes. Genetic information is encoded in the DNA sequence while, epigenetic information is defined basically by DNA modification (DNA methylation) and chromatin modifications (methylation, phosphorylation, acetylation and ubiquitination of histone cores). Combination of these modifications characterizes the chromatin configuration and the accessibility of genes to the transcription machinery and consequently, transcriptional regulation of the expression of genes. Cheng [21] introduced three categories by which transcriptional function is generally initiated and controlled: First, general intrinsic promoter and transcriptional machinery [2224], second, specific transcriptional regulatory factors [2527] and, third, the configuration and accessibility of chromatin structure and DNA to the transcriptional machinery through posttranslational modifications of histone and post replicational modification of DNA [2729].
3.1. Main Epigenetic Regulatory Mechanisms
Complex epigenetic regulation comprises several molecular signals that direct the expression of genes based on environmental changes and developmental status. Transcription factors, non-coding RNAs (ncRNAs) [30], DNA methylation, histone modification and chromatin remodeling are such epigenetic signals that mediate accessibility and expression of genes as needed. Transcription mainly defines a self-propagating state mediated by cis-acting and/or trans-acting regulatory mechanisms [31], and are able to establish epigenetic states through cis-acting [32] and non-coding polycomb domains [31,33]. Reinforcement of epigenetic states happens through mutual relationship between DNA methylation and histone modifications [34]. DNA methylation postulates a reinforcing signal for other regulatory mechanisms whose functions are not that much strong [31].
DNA methylation and histone modification are two important mechanisms for modulating the chromatin structure and regulating the expressions of the genes (for review see [35]). Epigenetic regulation is a complex phenomenon that consists of a variety of different processes [21] such as imprinting [36], X chromosome inactivation [37] and gene silencing [38,39]. In addition it encompasses the development of an embryo [4043] and placenta [4446], nuclear reprogramming in SCNT embryos [3,6] and carcinogenesis [47,48].
3.2. Transcriptional Regulation
The transcriptional regulation of genes is mainly directed by different strategies. These include the state of genomic methylation [21], chromatin configuration [49,50], chromatin structural variations (euchromatin and heterochromatin) [51,52], and chromatin modifications [53]. Chromatin modification in turn is influenced by methylation, acetylation and phosphorylation, as well as polycomb proteins [54] and matrix attached region [55]. Transcriptional regulation is mostly controlled by the methylation pattern of the genome. DNA methylation on specific CpG dinucleotide (CpG) located in a cluster (CpG islands) is the regulatory mechanism by which expression of gene is either activated or suppressed (for review see [56]). Moreover, chemical modifications of chromatin histone cores are mediated by DNA methylation of CpG islands [57]. These modifications have a mutual relationship with each other [58]. Germ cells and embryonic cells during early development are two epigenetic sites where methylation patterns erase, establish and reestablish [59].
3.3. Epigenetic Reprogramming During Embryogenesis
In mammals, epigenetic reprogramming in germ cells and during preimplantation, especially its effects on imprinting genes, predominantly establishes developmental stages [60]. The DNA methylation patterns characterize developmental status during cell differentiation. In the concept of epigenomics, molecular signals are responsible to establish the proper expression of embryo-specific genes, mainly during gametogenesis and embryogenesis. Therefore, the main issue for a successful SCNT is the establishment of these modifications, occurring during embryogenesis, which should be similar and ideally identical to its normal embryo counterpart. However, undoubtedly, several lessons are still to be learnt regarding epigenetic modifications during gametogenesis.
3.4. Epigenetic Features of DNA Methylation
As mentioned before, DNA methylation and histone modification are the main epigenetic factors, by which gene expression could be regulated, and have important roles in nuclear reprogramming during embryogenesis. DNA methylation is a heritable epigenetic marker by which expression of a gene may be regulated through alteration in the local chromatin structure that mostly happen within the CpG islands and imprinted genes at cytosine carbon 5 within palindromic dinucleotide 5′-CpG-3′ and differentially methylated domains (DMDs) respectively (see review [60]). Cytosine residue of CpG is the site for DNA methylation by which gene expression is regulated. Generally, DNA methylation at CpG sequences suppresses the expression of the methylated gene [61]. CpG islands are usually located within repetitive elements such as centromic repeats, satellite sequences and ribosomal RNA genes [62,63]. DNA methylation can be varied in terms of patterns and the level of global/regional DNA methylation, is specific to developmental stages [64] and origin of tissue [16,65]. In fact, the mature parental gametes at fertilization are significantly methylated. For instance, DNA of sperm, in comparison with that of the oocyte, is more methylated [66,67] and, undergoes demethylation after fertilization [6870]. However, imprinted genes and some retrotransposons mostly remain methylated. In mouse, hypermethylation pattern in repetitive regions and heterochromatin region has been observed; whilst in gene-specific region of DNA hypomethylation is predominant [17,71,72]. Abnormal DNA methylation of various repetitive elements in cloned blastocysts was reported for the first time by Kang and coworkers [73]. Methylation of imprints, monoallelic expressed genes [74,75], on the other hand, is a maintained (not de novo) and highly conserved event [76,77]. Recently, in a human study, comparison between embryonic stem cells and differentiated cells illustrated that there are a number of methylated cytosine in non-CpG regions of the embryonic stem cells [78].
3.5. DNA Methylation Signals
DNA methylation is under the control of two types of signals: cis-acting signals and trans-acting signals. IGF2R, SNRPN, H19 and RASGRF1 are genes regulated by cis-acting signals (see review [79]). Global DNA methylation takes place especially after fertilization and with different rate of demethylation that is specific to either parental genome [61]. Cell cycle observations reveal that paternal demethylation generally happens during the first cell cycle but maternal alleles take a few cycles to be demethylated [80]. After fertilization, imprinting control regions (ICRs) methylation is established in a sex-dependent manner [61]. Despite the maintained methylation pattern in somatic cells, methylation pattern in germ cells needs to be appropriately reestablished to provide a methylation pattern that is heritable to the next generation. This suggests that methylation is modulated in a sex-dependent manner [81]. Although hypomethylation of female germ line seems not to be correlated to the sex chromosomes, their regulation is thought to be associated with genital ridge. However, in the male germ line it is regulated by both mechanisms [81,82].
3.6. DNA Methylation Analysis
Epigenetic studies are strongly involved in DNA methylation. Analysis of the methylation patterns is the main approach in different studies that focuses on gene regulation. The cytosine 5 methylation in the context of CpGs mostly takes place within CpGs islands at the promoter region of genes and this leads to suppression of the expression of the gene. Several studies correlate aberrant methylation pattern of DNA to developmental failure during embryogenesis [8385] and placentation [86,87] as well as several diseases and disorders [8891] (for review see [92]). DNA methylation techniques cover a wide range of analysis from gene specific, locus specific to entire genome analysis using proper methods categorized in four groups based on DNA methylation analysis techniques [93]: in the first category cytosine residues are converted to Uralic by a bisulfite conversion, the second category is based on methylation-sensitive restriction endonuclease, enrichment based methods and the last is the capturing method based on the affinity to retain methylated DNA [94,95].
3.7. Regulatory Factors in DNA Methylation
As mentioned before, DNA methylation is a common epigenetic modification taking place by enzymatic reactions to be added to the cytosines at CpG, mostly known as repetitive elements and imprinted genes [79]. Generally, DNA methylation is classified either as de novo methylation or maintained methylation. Therefore, there are two classes of enzymatic: de novo methyltransferases and maintenance methyltransferases [96,97]. In mammals, DNA methylation occurs by the addition of a methyl group from S-adenosylmethionine to Cytosine using DNA methyltransferases (DNMTs). DNMTs are trans-acting factors targeting DNA sites for methylation using cis-acting signals. There are a number of mammalian DNMTs (see Table 1) that have been identified since 1980s [98] (for review see [99]).
Table 1
Table 1
Types of DNA methyltransferases and their epigenetic functions.
3.8. DNA Methyltransferases
DNA methylation at cytosine 5 nucleotide is catalyzed by DNMTs. This family of enzyme is vitally important in epigenetic regulation which modulates the expression of genes especially imprinted ones as well as X chromosome inactivation [114,115]. There are five main DNMTs that are important in de novo and/or maintenance DNA methylation: DNMT1, DNMT10, DNMT3a, DNMT3b and DNMT3L [99]. DNMT1, DNMT2 and DNMT3 are mostly characterized DNMTs that can categorize either maintenance or de novo DNMT. DNMT1 is a maintenance DNMT that methylates both imprints and non-imprints genes. DNMT2 seems to have a regulatory role in DNA methylation but the mechanism and its role in methylation maintenance or de novo remains unclear. DNMT3 as a de novo DNMT (DNMT3a) is a key factor in imprints’ methylation. Its isoforms are suggested to have roles in global DNA methylation in germ cells [116].
DNMT3L is defined as an imprints’ regulatory candidate for DNA methylation by regulating NMT3a/b [117]. The expression of DNMT1 gene has a positive correlation with DNA methylation status on the satellite I region. Consequently, it has been shown that in vitro development of bovine SCNT embryos to the blastocysts state can be enhanced through down regulation of DNMT1 [118]. It is also shown that the DNMT is responsible for ICRs methylation [109]. Moreover, transcriptional analysis on the pS2/TFF1 during cell cycles reveals that DNMTs carry out two distinct actions, namely methylation and demethylation of CpGs [119].
In comparison to the male germ line in which the establishment of ICR methylation of an imprinted gene, H19, is regulated by DNMT3a and DNMTL [109,113], DNMT3L is the de novo methylating regulatory factor for the female germ line [109]. In the female germ line, DNMT3L establishes the methylation of ICRs that selectively interact with histone H3 [120]. This evidence in addition to DNMT3L’s stimulating role for DNMT3a and DNMT3b [117] shows its potential in chromatin mark-specific recognition and methylation establishment [61]. Promoter methylation-mediated DNMTs show down regulation of DNMT1 and up regulation of DNMT3L in the human placenta and brings strength to the capability of DNMT family in the establishment of de novo DNA methylation in extraembryonic tissue [46]. A novel DNMT3b splice variant, DNMT3B3Δ5, is highly expressed in pluripotent embryonic stem cell and in contrast, is repressed during differentiation [121].
In a human study on DNMTS, global hypomethylation is shown to be induced by significant reduction in the expression of DNMT3A, DNMT3b and DNMT1 using microRNA-29b [122]. DNMT3L by itself has no methyltransferase activity; however, its association with the DNMT3 family seems essential for de novo methylation in mice [123]. There are some evidence on the activity of DNMT1 in the establishment of methylation at non-CpG regions [55] and CpG islands [21,124,125]. Histone modification and CpG spacing are able to direct DMR methylation of imprints [21]. Crystallographic analysis showed that de novo DNA methylation might be controlled by specific histone modifications in that a heterotetramer structure, assembled from DNMT3a and DNMTL, provides two active sites of CpG that are 8–19 base-pair distance from each other [126128]. A study on chromosome 21 also Reinforces the crucial role of CpG spacing in DNA methylation [129]. Active demethylation in mammalian genome seems promising, however, there has been no report of an enzyme that can catalyze this reaction [130]. Some studies have emphasized an active demethylation process, independent from DNA replication [131,132]. In fact, demethylation of the paternal alleles is an active event that happens rapidly after fertilization. The maternal genome, however, demethylates during first cell cycles in which demethylation mostly appears to be an inactive process. In addition to DNA methylation and histone modification, ncRNAs and regulatory proteins are the most studied epigenetic mechanisms that modulate epigenetic reprogramming. Small interfering RNAs (siRNAs) transfection is a technique to silence DNMT mRNA and modify the DNA methylation pattern in cells [6]. In a recent study, To examine the efficacy of the technique in SCNT embryos, DNMT1 RNA was silenced using siRNA in SCNT bovine embryo which demonstrated the capability in nucleus reprogramming through inducing DNA methylation [118]. In the expression of H19 in the male germ line, DNMT3a and DNMTL are counterparts and reached their maximum [133,134] on embryonic day 13 while there is no methylation on the H19 ICR, in mouse [135]. In addition, these enzymes seem not to be specific for DNA binding [99], suggesting direct/indirect interactions with specific chromatin modifications [61,136,137].
3.9. Epigenetic Features of ncRNAs
The cluster-oriented imprinted genes are laid in ~1Mb length base pair, containing parental expressed genes, ncRNA sequences that regulate the nearby imprinted genes [138141]. ncRNAs are mostly placed in clusters and regulated by ICRs [142]. The GNAS and KCNQ1 are examples of such imprints; containing ncRNAs that mediate the gene expression [143,144]. ncRNAs are divided into two groups, small ncRNAs and long ncRNAs. Small ncRNAs attach chromatin modifiers to specific genome sequence [145] and may interact with either RNA, single stranded DNA or double stranded DNA [1,146]. Long ncRNAs have complex tertiary structure and act globally to bridge chromatin modifiers to the genome [147]. But there are some evidences for local function of long ncRNAs, which is considered to function in cis-acting regulation of parental imprinted gene and inactivation of chromosome X [1].
In mammalian transcription of ncRNA genes is an important feature. ncRNAs usually are classified based on their mature length, location and orientation according to the nearest protein-coding gene, and their function which could be cis or trans [148150]. Macro RNAs, such as inactive X-specific transcript (Xist) and X (inactive)-specific transcript, antisense (Tsix), are categorized as cis-acting ncRNAs that usually locate within clusters of imprinted genes. On the other hand, short ncRNAs such as short interfering RNAs, micro RNAs, piwi-interacting RNAs and short nucleolar RNAs are categorized as trans-acting ncRNAs (for review see [151]) [148]. Koerner (2009) concluded that chromosomes express macro ncRNA usually do not express imprinted mRNA genes and the expression of imprinted macro ncRNAs may be regulated by an unmethylated imprint control element [148]. Moreover, there are a number of evidences that show trans-acting regulators for imprinted small ncRNAs such as Snurf-SNRPN and Dlk1-Gtl2 [152,153]. It has been shown that ncRNAs have a critical role during development. For instance, two ncRNAs, Dicer1 and Dgcr8, show developmental impact in mice [154,155]. Moreover, studies on effects of ncRNAs during animal embryogenesis show their specific and crucial role during embryonic development (for review see [156]). Micro ncRNAs, specifically, show precise control on expression of imprinted genes during development [157]. For instances, miR-15 and miR-16 are important in early embryonic development [158], miR-1, miR-133 and miR-206 in development of skeletal and heart muscle [159,160], miR-124 in neuronal development [161] (for review see [162]). During placentation, ncRNAs such as KCNQ1OT1, a long ncRNA, also illustrate a leading role in imprinted genes regulation [163165]. Regulation of ncRNAs is an important silencing mechanism in plancenta (for review see [148]). It was shown that the repression of imprinted genes during gestation is directly regulated by micro RNAs during placentation and embryogenesis [166,167]. It seems that ncRNAs targets placental histone methyltransferases by ncRNAs through chromatin modification [148].
3.10. Epigenetic Features of Small RNAs
Small RNAs (terminologically different from ncRNAs), generated by activity of RNaseIII enzymes (reviewed in [168]), have variety of biological functions such as heterochromatin formation, mRNA inactivation and transcriptional regulation [169,170]. Generally, their bioactivity is due to their association with Argonaute (Ago)-family proteins [171]. microRNAs (miRNAs), endogenous small interfering RNAs and Piwi-interacting RNAs (piRNAs) are classes of small RNAs. In mammalians, small RNA-associated Ago proteins are mostly classified into Piwi subfamily and Ago subfamily (for review see [171]). miRNAs to do their biological activity, which is post translational regulation by acting on mRNAs, needs to be bound by Ago subfamily proteins (for review see [170]). Moreover, regulation of most miRNAs may control by developmental signaling [172]. piRNAs are mostly bound by Piwi subfamily proteins and have a critical role during gametogenesis [173] in germ line [174]. This subfamily protein has shown to have a critical role in regulation of germline stem cells [175].
3.11. Epigenetic Features of Chromatin Modifications
Chromatin structure is crucial for gene regulation/expression, which is carried out by exploiting recruitment of protein complexes [29]. Euchromatin structure of embryonic stem cells is a predominant chromatic structure that allows for global gene expression accessibility [176] and facilitates reprogramming to the pluripotent state. It is not surprising that histone modifications might in turn influence the global gene expression by modulating chromatin configuration [177]. Covalent modification of the core histone has a critical role in the regulation of gene expression through acetylation and methylation. Chromatin modification and their function are important especially for gene regulation. Kouzarides (2007) reviewed a number of chromatin modifications characterized by mass spectrometry (for nucleosomal modification) and specific antibodies (for global histone modification) [178]. Cellular condition is the key element for such modifications and these chromatin modifications, as a dynamic procedure, are mediated by a number of histone-modifying enzymes that can fascinate unravels chromatin, recruitment of nonhistone proteins and transcriptional regulation (for review see [178]). Chromatin modifications, to regulate gene expression, are mostly implied be a number of chromatin modifications such as acetylation/deacetylation, phosphorylation, lysine/arginine methylation, deimination, ubiquitylation/deubiquitylation, sumoylatio, ADP ribosylation and proline isomerization which are properly reviewed by Kouzarides (2007) [178].
Histone acetylation is the main type of histone modification during oogenesis, and it is shown that histone acetylation is critical in epigenetic reprogramming [179,180]. For instance, in vitro study on acethylation of histones in cloned porcine blastocyst showed that increase the level of acetylation may enhance the embryonic development [181,182]. Generally, hyperacetylation of histone H3 and H4 improve the accessibility of nucleosome to transcriptional machinery [183]. The level of histone acetylation may correlate with the regulation of the expression of genes because more histone acetylation the more expression of a given gene, and vice versa [180]. As mentioned before, histone modifications and DNA methylation are cooperative. Histone modification is able to direct DNA methylation as shown in H3 in Neurospora crassa [184,185] (for review see [186]). Results from recent studies [187,188] have recapitulated that some chromatin modifiers directly act in a cis-acting manner [31]. However, a study on the relationship between DNA methylation and histone methylation suggests that they act mostly independently [189]. The affinity of UHRF1 binding protein to the nucleosomal H3K9me3 increases if CpG islands at the nucleosome are methylated but in contrast, in the absence of DNA methylation KDM2A binds to nucleosome having H3J9me3 [190]. Two epigenetic markers, H3K27me3 and CpG DNA methylation, at the RASGRF1 locus, are interdependent and antagonistic so they are more likely to exclude each other at the same loci [191]. The SNF2 family is an ATP-dependent remodeling complex. In this family, LSH has a role in establishment of normal DNA methylation. A null mutation in Hells gene, codes for LSH that results in the reduction or loss of methylation. Besides, this study suggests the importance of LSH in de novo methylation during embryogenesis [192]. Although histone methylation at H3K4 is able to control methylation at DMR of imprinted genes in an allele-specific manner [193,194], it seems to have preventive influence in terms of de novo methylation in mammalian somatic cells and may require low promoter methylation [195,196]. Furthermore, mutation in genes, coding for histone methyltransferase such as EZH2 and G9a [197,198] and histone deacetylases like HDAC1 [199] leads to premature death of mammalian embryos typically in less than ten days from fertilization.
After fertilization, a mammalian zygote undergoes proliferation and development. Although there are many active parental genes, involved in a normal embryo development, there are a few genes with bias regulation and transcription, referred to as imprinted genes [61]. Imprinting genes are important for normal embryonic development in mammals. Imprinting genes are selectively (on bias) expressed from a single parental allele [200] and conserved in their molecular structures and epigenomics [75,201]. These genes, essential for normal development, are expressed in a parent-specific manner, regulated by complex epigenetic mechanisms (e.g., DNA methylation, post-translational histone modification) using epigenetic markers (e.g., DNA methylation) [61]. The conflicting interests of parental, imprinted genes are hypothesized as maternally and paternally expressed imprints suppress and enhance the fetal growth respectively (see review [60]). In the nucleus, imprinted genes are mostly placed in a cluster orientation but some are identified as isolated ones [72] such as Nap1l5, Nnat, Inpp5f_v2 [202206] and Gatm, Dcn and Htr2a (for review see [207]). Imprints that are placed within CpG rich region are mostly in clusters, controlled by imprinting the control regions through DNA methylation and histone modifications [58,208,209]. Regulations of imprinted genes are generally proceeded through DNA methylation, post translational histone modification and ncRNAs [210]. In addition, active imprinted genes (expressed allele) contains the allele-discriminating signal (ADS) and the de novo methylation signal (DNS) that are necessary for establishing or maintaining methylation [211,212]. For instance, SNRPN is a paternally expressed imprint whose regulation is similar to that of IGF2r [212]. Human SNRPB contains two DNS signals; an ADS signal and a signal to maintain paternal imprint (MPI) [213].
Methylation of Imprinted Genes and Its Abnormalities in Cloned Animals
Short regions of DNA, described as differentially methylated regions (DMRs), are marked by methylation in a parental specific manner and therefore the expressions of such genes are monoallelic. Regulation of clusters of imprinted genes and their activities are mostly controlled by differentially methylated ICRs. In fact, ICRs are DMRs that obtain methylation on one allele (bios) and regulate clustered imprinted genes [138]. In the other words, those DMRs that have a critical role in maintaining imprinting are known as ICRs [81]. CpG spacing suggests a potential influence on ICRs recognition and DMRs methylation in imprints [126]. Moreover, the transcriptional system, especially those traversing ICRs, are considered a common requirement to open chromatin domains, and make targets available for methylation specially in the germ line [32]. Besides, an in vivo study in a mouse model illustrated a novel cis-acting function for the H19 ICR [214]. This study shows changes in the size and CpG density that coincide with biallelic expression of the H19 without any detectable alteration in the methylation pattern. The researchers concluded that, in addition to CTCF sites, there are sequences within the ICR that are essential for its regulatory function. Moreover, the ICR size and CpG density are of determinant elements.
Maternal alleles are dramatically more exposed to ICRs methylation than paternal ones [61,138]. Maternal alleles are mostly methylated on promoters of antisense transcripts but those of paternal alleles are placed between genes (non-promoter regions), suggesting that parental imprinting methylation acts differently [215]. In general, there is higher degree of methylation of the maternal ICRs allele in comparison with that of paternal allele [61]. The H19 is an example of imprinted genes whose preference is to be expressed from maternal allele. Methylation of the DMDs of H19, maternally expressed imprinted gene, is needed for maintenance methylation [141].
DMRs of imprints, mostly, epigenetically signal for monoallelic expression of the gene. IGF2 encodes a fetal growth-factor and is predominantly expressed from the paternal allele, while H19 is expressed from the maternal allele and encodes a transcript which may reduce cellular proliferation. In mouse, IGF2 has a few identified DMRs named DMR0, DMR1, DMR2 and DMR3 among which the first two DMRs are positioned upstream and DMR2 within the IGF2 gene [216218]. Recently, an intragenic regulatory DMR has been reported within the last exon of the IGF2 gene [81]. The comparison between methylation patterns of IGF2 DMR from parthenogenetic and androgenetic blastocysts on one hand and that evolved from a normal zygote suggests that in normal embryos, paternal allele significantly contributes in the DNA methylation at the locus [81]. Methylation on DMDs of imprints are initially established during gametogenesis and prior to parental pronucleus fusion in the zygote [61,219]. After fertilization, the intergenic DMR of bovine IGF2 undergoes demethylation followed by low level remethylation before blastocyst stage, which in turn precedes implantation by which the DMR is heavily remethylated. The study speculates that global methylation pattern of SCNT blastocysts is reprogrammed and maintained in a sex specific manner, similar to its normal counterpart. A recent study shows that, except for RASGRF1 DMR (paternally expressed imprinted gene), methylation of the most imprinted genes during mouse embryonic cleavage stages (preimplantation phase) are mainly controlled by maternal and zygotic DNA methyltransferase 1 (DNMT1) protein family [220].
Abnormalities at imprinted loci have been observed in cloned mammals. In cloned cattle abnormal imprinted gene profiles have been observed especially in the expression of IGF2 and H19 [221]. In the Bos taurus model, the IGF2 and H19 (IGF2/H19), a conserved cluster of imprinted gene, showed significant variations from the normal pattern, mostly hypomethylation, associated with abnormal expressions of the H19 (but not IGF2) from both alleles in methylation pattern of DMRs [17,222]. Moreover, methylation pattern which mostly occurs in early embryogenesis is dependent on developmental stage and specific to different tissues, as was studied in IGF2/H19 [218].
Super ovulation, also, can cause abnormal imprinting patterns in oocytes [223] that might be attributed to the reduced expression of imprinted parental alleles, SNRPN, PEG3 and KCNQ1OT1, but to increased methylation of H19 [224]. MII oocytes of cloned porcine showed mostly unmethylated profiles of DMR [225]. A recent study on bovine SCNT showed that significant demethylation at the H19 DMD is attributed to biallelic expression of the imprint which might lead to decline in the rate of implantation [226]. Moreover, biallelic expression of H19 in bovine is correlated to hypermethylation of the paternal H19 differentially methylated domain and locus anomalies cause low SCNT efficiency in cattle [226].
Gametogenesis and embryogenesis involve epigenetic reprogramming to establish proper epigenetic marks and gene regulation. Generally, epigenetic pattern of the genome first reprograms and reestablishes during gametogenesis. The second round of reprogramming and maintenance happens after fertilization, especially during preimplantation of the embryo [61] (Figure 2). Gametogenesis in both sexes involves methylation of DMRs, reestablished in a parent-specific manner [60]. Epigenetic reprogramming is mostly characterized during gametogenesis and early embryonic development especially prior to the zygotic implantation [227]. In fact, during gametogenesis (spermatogenesis and oogenesis) the methylation patterns of these genes are erased and reestablished. These modifications are continued after fertilization and during preimplantation specifically within non-imprinted genes [225] (for review see [180]). Gametogenesis involves sex-specific, epigenetic remodeling of male and female germ lines that matures the gametes for fertilization and constitutes proper regulatory processes [180]. Epigenetic reprogramming in sperm begins with DNA demethylation, followed by DNA remethylation and de novo methylation to chromatin modification and histone-to-promatine transition [180,228]. Moreover, during spermatogenesis, testis specific linker histones occupy somatic linker variants. Among the histone variants centromere protein A appears to be epigenetically important during spermatogenesis [180]. Spermatozoa have a transcriptionally inactive and highly condensed chromatin structure. During spermatogenesis in rats, paternal-specific imprinted genes are prone to hypomethylation due to estrogen-associated signaling [229]. In the male germ cells, DMR of IGF2/H19 acquires DNA methylation during spermatogenesis, however, in the female germ cells, the DMR possesses the zinc finger protein CTCF by which the DMR defends against methylation so the allele is able to be expressed [230]. Through fertilization, paternal genome undergoes a series of remodeling events which are controlled by the activity of the oocyte, and the protamine replaced by oocyte-supplied histone and possessing maternal chromatin related proteins [231].
Figure 2
Figure 2
Establishment and maintenance of imprinted genes (epigenetic regulation) during mammalian gametogenesis and development. Sex specific establishment of DNA methylation of imprinted genes occurs during gametogenesis. Just after fertilization, protamine (more ...)
DNA methylation is a sex bias phenomenon. As opposed to the male mouse embryonic germ cells, the female is not that much prone to methylate IGF2 receptor, IDF2 and H19 [82,232234]. The same result has been illustrated during the blastocyst stage. It has been shown that in bovine, there is a significant tendency for methylation in the male in comparison to that of the female [81]. Piwi proteins (mili and miwi2) are expressed only in germ line, which are responsible for the establishment of de novo DNA methylation in transposons, and it is shown that PiRNAs directs DNA methylation in the male mouse germ cells through which the transposon is silenced [235237]. In the other words, Piwi/PiRNA complex appears to guide the de novo methylation at transposons [235,237] and deactivate transposons within a germline [238]. PiRNAs and siRNAs such as the one located within AU76, a pseudogene of RANGAP1, negatively regulates transposons through their cis-acting function in mouse oocytes as well as establishes the methylation of retrotransposons in the male mouse germ line [235,237,239].
Somatic environment of the male/female germ line shows their influence in DNA methylation of imprints [82]. Using sex-reversed mice to evaluate sex-specific methylation pattern in vivo, the germ cells are found to be responsible for female/male imprints during oogenesis/spermatogenesis, though sex chromosome constitution shows significant influence on male germ line for imprint methylation [82]. It seems probable that somatic environment of the genital ridge and that of chromosomal constitution have key roles in the establishment of imprinted genes. RASGRF1, paternally expressed imprinted gene, is essential in the male germ line [240,241] suggesting a regulatory mechanism containing DMD methylation and the repeat sequences, by which methylation of the germ line is established [79].
Normal fetal development is dependent on proper development of embryo and placenta. These developments are modulated through epigenetic signals during gestation. Although these molecular signals are controlled by the same epigenetic mechanisms, their regulation is independent of each other and may follow different patterns during embryogenesis in comparison to placental development. During pregnancy, most monoallelic expressed genes carry out in extraembryonic tissues, such as trophoblast and yolk sac, regulate the development and function of placenta [44,201]. In placenta, this regulation seems to be directed by histone modification and ncRNAs through DNA methylation [201]. Embryo-placental development is a complex modulating phenomenon through which imprints undergo necessary maintenance, establishment and/or reestablishment. Placental development is under the control of IGF2 and its degradation receptor, IGF2r [242]. IGF2, paternally expressed imprint, codes for embryo-placental growth factors. However, its receptor seems an unorthodox, imprinted gene [243].
Embryogenesis involves global methylation to erase and remethylate the methylation pattern. During early embryogenesis, methylation re-establishment occurs mostly within CpG islands and the imprints regulate in a sex-specific manner based on the new gender [79,244,245]. The demethylation mostly happens during primordial germ cells (PGCs) migration towards the genital ridge [79,246,247]. It is hypothesized that histone replacement and chromatin changes, using DNA repair mechanisms, are in accordance with the epigenetic reprogramming of PGC [61]. Evidences for such associations come from the chromatin modification markers, for instance H3K9me2/3, H3K27me3, H3K4me2/3, H3K9ac, NAP-1 and HIRA, during early embryogenesis [248].
Just after fertilization, pre-implantation phase, promatines replace with histones and some level of histone modifications occur. Active demethylation of paternal pronucleus of the zygote starts and follows with passive demethylation during the cleavage states. Re-activation of the inactive X chromosome inactivation is the last significant change of the female embryo during pre-implantation development (for review see [43]). Chromatin modifications during germ line development begin with demethylation of imprinted genes in primordial germ cells, in a sex-dependent manner [246]. Then, during female gametogenesis, this modification proceeds to form primary oocytes, and follows to reestablishment of maternal-specific methylation pattern during growth and maturation of oocyte [123]. In male gametogenesis, a number of modification factors are involved. During spermatogenesis, histones undergo hypoacetylation. Especially, DNMTs are significantly important in the alteration of Leptotene to Pachytene. In this transformation, DNA methylation, histone methylation and histone deacetylation are counterparts [249]. The last modification to produce a mature sperm is the promatine formation (for review see [53]).
Early embryonic mouse shows high level of DNA methylation and expression of imprinted genes. The epigenetic pattern is maintained in somatic cells but erased in the PGC about 11.5–12.5 embryonic day [61]. At this time, the expression of the imprinted genes in PGC is biallelic and reestablishes during prenatal (in a male embryo) and postnatal stages (in a female embryo) [61,246,250]. Mammalian promoters enriched in H3 K27 trimethylation [251] and H3 K4 trimethylation [252] are mostly occupied by polycomb group (PcG). Besides, PcG proteins influence the pluripotency of embryonic stem cell [253257]. Study on mouse embryos revealed the regulatory mechanism for imprints in which DNA configuration is the key silencing factor. An imprinted gene, KCNQ1, is paternally repressed by ncRNA, KCNQLOT1, in association with PcG proteins (EZH2 and Rnf2) at Cdkn1c, Cd81 and Tssc4 cis genes [167]. An in vitro study on the expression of imprinted genes, H19 and SNRPN, in male mouse [258], suggested a mostly intrinsic, sex-specific reestablishment of DNA methylation (after DNA demethylation) in the male germ line. However, there is still a probability that somatic cells at earlier stages may influence DNA methylation [61].
In mammals, imprinting has an important role in extraembryonic tissue. Their activation pattern seems to be tissue-specific as they are varied between embryonic imprints and placental imprints, for instance in mouse, placental imprints are mostly paternally repressed [201]. The authors suggested an evolutionary relation between placenta imprints and that of chromosome X repression. These findings propose that independent regulatory mechanisms are active in the embryo and in the placenta [259]. The regulatory mechanism suggested for imprints expression, is DNA methylation through histone modification and ncRNAs [201]. Research on a mouse model postulates that the regulation of the expression of imprints is not very firm in the trophoblast as it is in the embryo [260]. In fact, histone methylation maintains the silencing of the inactive allele of the imprints in mouse extraembryonic tissue, placenta. Further, the absence of histone methyltransferase G9a that has aberrant effects on placental imprinted cluster, Kcnq1. Retrotransposon-derived Peg 11 (paternally expressed 11) or Rtl1 (Retrotransposon-like q) is a paternally expressed imprinted gene responsible for the maintenance of placental development especially in fetal capillary development [261,262]. In placenta, repressive histone modification seems more crucial for the maintenance of imprinted genes [201,260]. Moreover, ethanol-induced growth inhibitory effects on the methylation of paternal allele H19, suggests CCCTC-binding factor site as a epigenetic switch in placenta [263]. A recent study on methylation status of placental PEG10 emphasizes the importance of normal methylation of placental imprints for normal development of SCNT in cloned cattle. The placental PEG10 shows a similar methylation pattern in the cloned calves, which survived and were healthy, in comparison with normal calves. Further, the cloned calves that died because of developmental failure, showed hypermethylation in PEG10 [264]. The importance of epigenetic regulation for proper placental development is obvious. Thus, unsurprisingly, SCNT paves the way to have a better understanding of placental development and molecular signals that modulate epigenetic regulation.
DNA methylation and PcG proteins are two main silencing epigenetic pathways that are in accordance with each other [265]. PcG proteins are epigenetic regulatory proteins combined in numerous protein complexes as well as individual PcG proteins and usually interact with histones. They are classified as polycomb repressive complexes 1 and 2 classes. EED is a PcG, which can modify histone and change chromatin structure. EZH2, a PcG protein, is a regulatory element for the methylation of CpG in which the protein is in direct contact with DNMTs. PcG proteins play a critical role in epigenetic regulation such as in higher organisms X-chromosome inactivation, imprinting regulation and restoring to pluripotent status [266,267]. Their epigenetic role is more in maintaining chromatin structure as well as reestablishment of transcriptional regulation (for review see [268]), especially during differentiation and development [255,269]. PcG are responsible for maintenance of repression of specific developmental genes [180]. CTCF is an essential factor in insulator’s function that regulates transcription in mammals [270]. It contains 11 zinc-finger DNA binding protein [271] with versatile functions [272,273] as well as a transcriptional activator [274] and a repressor [271,275] (see review [276] for more information). Studies show epigenetic activities of CTCF in regulation of imprints [277] and X chromosome inactivation [148,278,279]. However, post-fertilization methylation of the H19 ICR in a transgenic mouse model shows the necessity of the CTCF binding sites for the maintenance of the imprint pattern after implantation but not during pre-implantation phase [280]. A recent study on H19 ICR in SCNT bovine embryos reconfirms that significant demethylation of the gene prevents successful implantation of the embryo [226]. These investigators showed that the CTCF binding sites of the paternal allele are mostly unmethylated, and coincided with the expression of the H19, though during postimplantation period the methylation pattern and the expression profile of the gene was similar to control. Transcriptional regulation of genes is also associated with chromatin modification enzymes, such as HDAC1 [265], G9a [281] which are associated with DNMTs [282].
Creating live and healthy offspring through SCNT technique is only partially explained through epigenetic modifications. Clearly, somatic nuclei need to appropriately reprogram to the pluripotent state from which embryogenesis embarks. Most of the epigenetic modifications are probably mediated by DNA methylation and histone modifications. The epigenetic modifications reviewed here might explain some of the transcriptional regulatory mechanisms in SCNT reprogramming, which could influence embryonic gene expressions and might also affect the placental development during gestation. In contrast to genetic alterations, most epigenetic modifications are reversible, and the modulation of such modifications by reprogramming pluripotent genes in an embryo and placenta increase the amount of successes in animal cloning. In this review, we have highlighted the importance and possible epigenetic modifications that probably influences the efficiency of animal cloning. Proper regulation of these could further influence the life span of the cloned livestock via the epigenetic modulation of somatic gene expression. In addition to unraveling the mechanisms that have been described in the past decade, several other mechanisms would require additional careful investigation. As discussed, somatic profiles of DNA methylation, histone modifications and chromatin configuration must be erased and reprogrammed in a precise manner in terms of both timing and location. Embryo-specific marks must be acquired in cloned embryos, similar to its natural counterpart. For proper acquisition epigenetic marks take place during embryogenesis, and this is why understanding of the epigenetic modification through gametogenesis up to fertilization is crucial. Inappropriate modification and reprogramming would affect the embryo-placental development and, consequently, could lead to failure during gestation, abnormalities and syndromes. This review is intended to emphasize the importance of understanding nuclear reprogramming for proper SCNT and the importance of DNA methylation and chromatin modification in nuclear reprogramming. Failures in the reprogramming will influence normal development of embryo and placenta and cause several abnormalities. All efforts to illuminate the complexity of epigenetic reprogramming that produces healthy cloned offsprings are necessary in order to have a better insight into the interaction between genomics and epigenomics.
Acknowledgments
This work was funded by research grant UM/MOHE High Impact Research Grant (HIR Grant No. F000009-21001) from the University of Malaya. The authors thank V. Bhavananthan, Nazia Abdul Majid and Sheila Golbabapour for their critical advice on the manuscript.
1. Bonasio R., Tu S., Reinberg D. Molecular signals of epigenetic states. Science. 2010;330:612–616. [PMC free article] [PubMed]
2. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature. 2008;454:49–55. [PMC free article] [PubMed]
3. Yang X., Smith S.L., Tian X.C., Lewin H.A., Renard J.-P., Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 2007;39:295–302. [PubMed]
4. Rideout W.M., Eggan K., Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science. 2001;293:1093–1098. [PubMed]
5. Keefer C.L. Lessons learned from nuclear transfer (cloning) Theriogenology. 2008;69:48–54. [PubMed]
6. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature. 2010;465:704–712. [PMC free article] [PubMed]
7. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. [PubMed]
8. Pells S., Di Domenico A.I., Gallagher E.J., McWhir J. Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells. 2002;4:331–338. [PubMed]
9. Tada M., Takahama Y., Abe K., Nakatsuji N., Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 2001;11:1553–1558. [PubMed]
10. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. [PubMed]
11. Yu J.Y., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920. [PubMed]
12. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature. 2010;463:1042–1047. [PMC free article] [PubMed]
13. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues—Implications for epigenetic reprogramming. J. Biol. Chem. 2004;279:52353–52360. [PubMed]
14. Constant F., Guillomot M., Heyman Y., Vignon X., Laigre P., Servely J.L., Renard J.P., Chavatte-Palmer P. Large offspring or large placenta syndrome? Morphometric analysis of late gestation bovine placentomes from somatic nuclear transfer pregnancies complicated by hydrallantois. Biol. Reprod. 2006;75:122–130. [PubMed]
15. Tamashiro K.L.K., Wakayama T., Blanchard R.J., Blanchard D.C., Yanagimachi R. Postnatal growth and behavioral development of mice cloned from adult cumulus cells. Biol. Reprod. 2000;63:328–334. [PubMed]
16. Hiendleder S., Wirtz M., Mund C., Klempt M., Reichenbach H.-D., Stojkovic M., Weppert M., Wenigerkind H., Elmlinger M., Lyko F., et al. Tissue-specific effects of in vitro fertilization procedures on genomic cytosine methylation levels in overgrown and normal sized bovine fetuses. Biol. Reprod. 2006;75:17–23. [PubMed]
17. Curchoe C.L., Zhang S., Yang L., Page R., Tian X.C. Hypomethylation trends in the intergenic region of the imprinted IGF2 and H19 genes in cloned cattle. Anim. Reprod. Sci. 2009;116:213–225. [PubMed]
18. Paoloni-Giacobino A. Implications of reproductive technologies for birth and developmental outcomes: Imprinting defects and beyond. Expert Rev. Mol. Med. 2006;8:1–14. [PubMed]
19. Smith L., Suzuki J., Jr, Goff A., Filion F., Therrien J., Murphy B., Kohan-Ghadr H., Lefebvre R., Brisville A., Buczinski S. Epigenetic anomalies associated with prenatal survival and neonatal morbidity in cloned calves. Anim. Reprod. 2010;7:197–203.
20. Heyman Y., Chavatte-Palmer P., LeBourhis D., Camous S., Vignon X., Renard J.P. Frequency and occurrence of late-gestation losses from cattle cloned embryos. Biol. Reprod. 2002;66:6–13. [PubMed]
21. Cheng X., Hashimoto H., Horton J.R., Zhang X. Mechanisms of DNA Methylation, Methyl-CpG Recognition, and Demethylation in Mammals. In: Trygve T., editor. Handbook of Epigenetics. Academic Press; San Diego, CA, USA: 2011. pp. 9–627.
22. Dvir A., Conaway J.W., Conaway R.C. Mechanism of transcription initiation and promoter escape by RNA polymerase II. Curr. Opin. Genet. Dev. 2001;11:209–214. [PubMed]
23. Sandelin A., Carninci P., Lenhard B., Ponjavic J., Hayashizaki Y., Hume D.A. Mammalian RNA polymerase II core promoters: Insights from genome-wide studies. Nat. Rev. Genet. 2007;8:424–436. [PubMed]
24. Tran K., Gralla J.D. Control of the timing of promoter escape and RNA catalysis by the transcription factor IIB fingertip. J. Biol. Chem. 2008;283:15665–15671. [PubMed]
25. Malik S., Roeder R.G. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem. Sci. 2005;30:256–263. [PubMed]
26. Hoffmann A., Natoli G., Ghosh G. Transcriptional regulation via the NF-κB signaling module. Oncogene. 2006;25:6706–6716. [PubMed]
27. Carrera I., Treisman J.E. Message in a nucleus: Signaling to the transcriptional machinery. Curr. Opin. Genet. Dev. 2008;18:397–403. [PMC free article] [PubMed]
28. Li B., Carey M., Workman J.L. The role of chromatin during transcription. Cell. 2007;128:707–719. [PubMed]
29. Berger S.L. The complex language of chromatin regulation during transcription. Nature. 2007;447:407–412. [PubMed]
30. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: Regulators of disease. J. Pathol. 2010;220:126–139. [PubMed]
31. Bonasio R., Tu S.J., Reinberg D. Molecular signals of epigenetic states. Science. 2010;330:612–616. [PMC free article] [PubMed]
32. Chotalia M., Smallwood S.A., Ruf N., Dawson C., Lucifero D., Frontera M., James K., Dean W., Kelsey G. Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev. 2009;23:105–117. [PubMed]
33. Schmitt S., Prestel M., Paro R. Intergenic transcription through a polycomb group response element counteracts silencing. Genes Dev. 2005;19:697–708. [PubMed]
34. Cedar H., Bergman Y. Linking DNA methylation and histone modification: Patterns and paradigms. Nat. Rev. Genet. 2009;10:295–304. [PubMed]
35. Hanley B., Dijane J., Fewtrell M., Grynberg A., Hummel S., Junien C., Koletzko B., Lewis S., Renz H., Symonds M., et al. Metabolic imprinting, programming and epigenetics—A review of present priorities and future opportunities. Br. J. Nutr. 2010;104:S1–S25. [PubMed]
36. Hore T.A., Rapkins R.W., Graves J.A.M. Construction and evolution of imprinted loci in mammals. Trends Genet. 2007;23:440–448. [PubMed]
37. Yen Z.C., Meyer I.M., Karalic S., Brown C.J. A cross-species comparison of X-chromosome inactivation in Eutheria. Genomics. 2007;90:453–463. [PubMed]
38. Miranda T.B., Jones P.A. DNA methylation: The nuts and bolts of repression. J. Cell. Physiol. 2007;213:384–390. [PubMed]
39. Lande-Diner L., Zhang J., Ben-Porath I., Amariglio N., Keshet I., Hecht M., Azuara V., Fisher A.G., Rechavi G., Cedar H. Role of DNA methylation in stable gene repression. J. Biol. Chem. 2007;282:12194–12200. [PubMed]
40. Shi L.J., Wu J. Epigenetic regulation in mammalian preimplantation embryo development. Reprod. Biol. Endocrinol. 2009;7 doi: 10.1186/1477-7827-7-59.. [PMC free article] [PubMed] [Cross Ref]
41. Wang J.L., Zhang M., Zhang Y., Kou Z.H., Han Z.M., Chen D.Y., Sun Q.Y., Gao S.R. The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol. Reprod. 2010;82:105–111. [PubMed]
42. Badr H., Bongioni G., Abdoon A.S.S., Kandil O., Puglisi R. Gene expression in the in vitro-produced preimplantation bovine embryos. Zygote. 2007;15:355–367. [PubMed]
43. Hajkova P. Epigenetic reprogramming—Taking a lesson from the embryo. Curr. Opin. Cell Biol. 2010;22:342–350. [PubMed]
44. Coan P.M., Burton G.J., Ferguson-Smith A.C. Imprinted genes in the placenta—A review. Placenta. 2005;26:S10–S20. [PubMed]
45. Fowden A.L., Coan P.M., Angiolini E., Burton G.J., Constancia M. Imprinted genes and the epigenetic regulation of placental phenotype. Prog. Biophys. Mol. Biol. 2011;106:281–288. [PubMed]
46. Ng H.K., Novakovic B., Hiendleder S., Craig J.M., Roberts C.T., Saffery R. Distinct patterns of gene-specific methylation in mammalian placentas: Implications for placental evolution and function. Placenta. 2010;31:259–268. [PubMed]
47. Schär P., Fritsch O. DNA Repair and the Control of DNA Methylation. In: Gasser S.M., Li E., editors. Epigenetics and Disease. Vol. 67. Springer; Basel, Switzerland: 2011. pp. 51–68.
48. Gronbaek K., Hother C., Jones P.A. Epigenetic changes in cancer. APMIS. 2007;115:1039–1059. [PubMed]
49. Baumann C., Daly C.M., McDonnell S.M., Viveiros M.M., de la Fuente R. Chromatin configuration and epigenetic landscape at the sex chromosome bivalent during equine spermatogenesis. Chromosoma. 2011;120:227–244. [PMC free article] [PubMed]
50. Ho L., Crabtree G.R. Chromatin remodelling during development. Nature. 2010;463:474–484. [PMC free article] [PubMed]
51. Lucia P., Fanti L., Negri R., Del Vescovo V., Fatica A., Pimpinelli S. The Heterochromatin Protein 1 positively regulates euchromatic gene expression by RNA binding. [accessed on 27 July 2011]. Aviable online: http://hdl.handle.net/10101/npre.2008.2687.1.
52. Girton J.R., Johansen K.M. Chromatin Structure and the Regulation of Gene Expression: The Lessons of PEV in Drosophila. In: van Veronica H., Robert E.H., editors. Advances in Genetics. Vol. 61. Academic Press; San Diego, CA, USA: 2008. pp. 1–43. [PubMed]
53. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002;3:662–673. [PubMed]
54. Simon J.A., Kingston R.E. Mechanisms of Polycomb gene silencing: Knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009;10:697–708. [PubMed]
55. Girod P.-A., Nguyen D.-Q., Calabrese D., Puttini S., Grandjean M., Martinet D., Regamey A., Saugy D., Beckmann J.S., Bucher P., et al. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat. Methods. 2007;4:747–753. [PubMed]
56. Shiota K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet. Genome Res. 2004;105:325–334. [PubMed]
57. Kim J.K., Samaranayake M., Pradhan S. Epigenetic mechanisms in mammals. Cell. Mol. Life Sci. 2009;66:596–612. [PMC free article] [PubMed]
58. Vaissiere T., Sawan C., Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 2008;659:40–48. [PubMed]
59. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell. 2010;143:508–525. [PMC free article] [PubMed]
60. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–1093. [PubMed]
61. Weaver J.R., Susiarjo M., Bartolomei M.S. Imprinting and epigenetic changes in the early embryo. Mamm. Genome. 2009;20:532–543. [PubMed]
62. Ooi S.K.T., O’Donnell A.H., Bestor T.H. Mammalian cytosine methylation at a glance. J. Cell Sci. 2009;122:2787–2791. [PubMed]
63. Walsh C.P., Bestor T.H. Cytosine methylation and mammalian development. Genes Dev. 1999;13:26–34. [PubMed]
64. Gopalakrishnan S., van Emburgh B.O., Robertson K.D. DNA methylation in development and human disease. Mutat. Res. 2008;647:30–38. [PMC free article] [PubMed]
65. Chang H., Zhang T., Zhang Z., Bao R., Fu C., Wang Z., Bao Y., Li Y., Wu L., Zheng X., et al. Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J. Nutr. Biochem. 2011 in press. [PubMed]
66. Howlett S.K., Reik W. Methylation levels of maternal and paternal genomes during preimplantation development. Development. 1991;113:119–127. [PubMed]
67. Monk M., Boubelik M., Lehnert S. Temporal and regional changes in dna methylation in the embryonic, extraembryonic and germ-cell lineages during mouse embryo development. Development. 1987;99:371–382. [PubMed]
68. Gehring M., Reik W., Henikoff S. DNA demethylation by DNA repair. Trends Genet. 2009;25:82–90. [PubMed]
69. Mayer W., Niveleau A., Walter J., Fundele R., Haaf T. Embryogenesis: Demethylation of the zygotic paternal genome. Nature. 2000;403:501–502. [PubMed]
70. Oswald J., Engemann S., Lane N., Mayer W., Olek A., Fundele R., Dean W., Reik W., Walter J. Active demethylation of the paternal genome in the mouse zygote. Curr. Biol. 2000;10:475–478. [PubMed]
71. Doherty A.S., Mann M.R.W., Tremblay K.D., Bartolomei M.S., Schultz R.M. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol. Reprod. 2000;62:1526–1535. [PubMed]
72. Mann M.R.W., Chung Y.G., Nolen L.D., Verona R.I., Latham K.E., Bartolomei M.S. Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol. Reprod. 2003;69:902–914. [PubMed]
73. Kang Y.K., Lee K.K., Han Y.M. Reprogramming DNA methylation in the preimplantation stage: Peeping with Dolly’s eyes. Curr. Opin. Cell Biol. 2003;15:290–295. [PubMed]
74. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293:1068–1070. [PubMed]
75. Ferguson-Smith A.C., Surani M.A. Imprinting and the epigenetic asymmetry between parental genomes. Science. 2001;293:1086–1089. [PubMed]
76. Mayer W., Niveleau A., Walter J., Fundele R., Haaf T. Embryogenesis—Demethylation of the zygotic paternal genome. Nature. 2000;403:501–502. [PubMed]
77. Tremblay K.D., Saam J.R., Ingram R.S., Tilghman S.M., Bartolomei M.S. A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nat. Genet. 1995;9:407–413. [PubMed]
78. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315–322. [PMC free article] [PubMed]
79. Holmes R., Soloway P.D. Regulation of imprinted DNA methylation. Cytogenet. Genome Res. 2006;113:122–129. [PubMed]
80. Santos F., Hendrich B., Reik W., Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 2002;241:172–182. [PubMed]
81. Gebert C., Wrenzycki C., Herrmann D., Groger D., Thiel J., Reinhardt R., Lehrach H., Hajkova P., Lucas-Hahn A., Carnwath J.W., et al. DNA methylation in the IGF2 intragenic DMR is re-established in a sex-specific manner in bovine blastocysts after somatic cloning. Genomics. 2009;94:63–69. [PubMed]
82. Durcova-Hills G., Hajkova P., Sullivan S., Barton S., Surani M.A., McLaren A. Influence of sex chromosome constitution on the genomic imprinting of germ cells. Proc. Natl. Acad. Sci. USA. 2006;103:11184–11188. [PubMed]
83. Horsthemke B. Genomic imprinting and imprinting defects. Med. Genet. 2010;22:385–391.
84. Hou J., Cui X.H., Lei T.H., Liu L., An X.R., Chen Y.F. Aberrant DNA methylation patterns in cultured mouse embryos. Prog. Nat. Sci. 2005;15:1079–1083.
85. Beaujean N., Taylor J., Gardner J., Wilmut I., Meehan R., Young L. Effect of limited DNA methylation reprogramming in the normal sheep embryo on somatic cell nuclear transfer. Biol. Reprod. 2004;71:185–193. [PubMed]
86. Wei Y., Zhu J., Huan Y., Liu Z., Yang C., Zhang X., Mu Y., Xia P., Liu Z. Aberrant expression and methylation status of putatively imprinted genes in placenta of cloned piglets. Cell. Reprogram. 2010;12:213–222. [PubMed]
87. Bourque D.K., Avila L., Penaherrera M., von Dadelszen P., Robinson W.P. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta. 2010;31:197–202. [PubMed]
88. Balassiano K., Lima S., Jenab M., Overvad K., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Canzian F., Kaaks R., Boeing H., et al. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the european prospective investigation into cancer and nutrition (EPIC-EURGAST) Cancer Lett. 2011;311:85–95. [PubMed]
89. Chung J.-H., Lee H.J., Kim B.-h., Cho N.-Y., Kang G.H. DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arch. 2011;459:201–211. [PubMed]
90. Estecio M.R.H., Issa J.-P.J. Dissecting DNA hypermethylation in cancer. FEBS Lett. 2011;585:2078–2086. [PMC free article] [PubMed]
91. Tada Y., Yokomizo A., Shiota M., Tsunoda T., Plass C., Naito S. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer. Int. J. Oncol. 2011;39:727–733. [PubMed]
92. Shames D.S., Minna J.D., Gazdar A.F. DNA methylation in health, disease, and cancer. Curr. Mol. Med. 2007;7:85–102. [PubMed]
93. Acevedo L.G., Sanz A., Jelinek M.A. Novel DNA binding domain-based assays for detection of methylated and nonmethylated DNA. Epigenomics. 2011;3:93–101. [PubMed]
94. Laird P.W. Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 2010;11:191–203. [PubMed]
95. Harris R.A., Wang T., Coarfa C., Nagarajan R.P., Hong C.B., Downey S.L., Johnson B.E., Fouse S.D., Delaney A., Zhao Y.J., et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 2010;28:1097–1105. [PMC free article] [PubMed]
96. Razin A., Kantor B. DNA Methylation in Epigenetic Control of Gene Expression. In: Jeanteur P., editor. Epigenetics and Chromatin. Vol. 38. Springer; Berlin, Germany: 2005. pp. 151–167. [PubMed]
97. Singal R., Ginder G.D. DNA methylation. Blood. 1999;93:4059–4070. [PubMed]
98. Bestor T., Laudano A., Mattaliano R., Ingram V. Cloning and sequencing of a cDNA-encoding DNA methyltransferase of mouse cells: The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 1988;203:971–983. [PubMed]
99. Chen T.P., Li E. Structure and Function of Eukaryotic DNA Methyltransferases. In: Schatten G.P., editor. Stem Cells in Development and Disease. Vol. 60. Academic Press; San Diego, CA, USA: 2004. pp. 55–89.
100. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000;9:2395–2402. [PubMed]
101. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., Silva A.J., Fan G.P. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 2010;13:423–430. [PMC free article] [PubMed]
102. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., MacLeod A.R. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 2003;33:61–65. [PubMed]
103. Chen T., Li E. Establishment and maintenance of DNA methylation patterns in mammals. Curr. Top. Microbiol. Immunol. 2006;301:179–201. [PubMed]
104. Mortusewicz O., Schermelleh L., Walter J., Cardoso M.C., Leonhardt H. Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl. Acad. Sci. USA. 2005;102:8905–8909. [PubMed]
105. Grandjean V., Yaman R., Cuzin F., Rassoulzadegan M. Inheritance of an epigenetic mark: The CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS One. 2007;2 doi: 10.1371/journal.pone.0001136.. [PMC free article] [PubMed] [Cross Ref]
106. Schaefer M., Lyko F. Solving the Dnmt2 enigma. Chromosoma. 2010;119:35–40. [PubMed]
107. Chedin F. The DNMT3 family of mammalian de novo DNA methyltransferases. In: Cheng X.D., Blumenthal R.M., editors. Modifications of Nuclear DNA and Its Regulatory Proteins. Vol. 101. Academic Press; San Diego, CA, USA: 2011. pp. 255–285.
108. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257. [PubMed]
109. Kaneda M., Okano M., Hata K., Sado T., Tsujimoto N., Li E., Sasaki H. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature. 2004;429:900–903. [PubMed]
110. Bourc’his D., Xu G.L., Lin C.S., Bollman B., Bestor T.H. Dnmt3L and the establishment of maternal genomic imprints. Science. 2001;294:2536–2539. [PubMed]
111. Chedin F., Lieber M.R., Hsieh C.L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl. Acad. Sci. USA. 2002;99:16916–16921. [PubMed]
112. Gowher H., Liebert K., Hermann A., Xu G.L., Jeltsch A. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L. J. Biol. Chem. 2005;280:13341–13348. [PubMed]
113. Webster K.E., O’Bryan M.K., Fletcher S., Crewther P.E., Aapola U., Craig J., Harrison D.K., Aung H., Phutikanit N., Lyle R., et al. Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. Proc. Natl. Acad. Sci. USA. 2005;102:4068–4073. [PubMed]
114. Klose R.J., Bird A.P. Genomic DNA methylation: The mark and its mediators. Trends Biochem. Sci. 2006;31:89–97. [PubMed]
115. Jurkowska R.Z., Jurkowski T.P., Jeltsch A. Structure and function of mammalian DNA methyltransferases. Chembiochem. 2011;12:206–222. [PubMed]
116. Sakai Y., Suetake I., Shinozaki F., Yamashina S., Tajima S. Co-expression of de novo DNA methyltransferases Dnmt3a2 and Dnmt3L in gonocytes of mouse embryos. Gene Expr. Patterns. 2004;5:231–237. [PubMed]
117. Suetake I., Shinozaki F., Miyagawa J., Takeshima H., Tajima S. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J. Biol. Chem. 2004;279:27816–27823. [PubMed]
118. Yamanaka K.I., Sakatani M., Kubota K., Balboula A.Z., Sawai K., Takahashi M. Effects of downregulating DNA methyltransferase 1 transcript by RNA interference on DNA methylation status of the satellite I region and in vitro development of bovine somatic cell nuclear transfer embryos. J. Reprod. Dev. 2011;57:393–402. [PubMed]
119. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature. 2008;452:45–50. [PubMed]
120. Ooi S.L., Henikoff S. Germline histone dynamics and epigenetics. Curr. Opin. Cell Biol. 2007;19:257–265. [PubMed]
121. Gopalakrishnan S., Van Emburgh B.O., Shan J.X., Su Z., Fields C.R., Vieweg J., Hamazaki T., Schwartz P.H., Terada N., Robertson K.D. A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol. Cancer Res. 2009;7:1622–1634. [PMC free article] [PubMed]
122. Garzon R., Liu S.J., Fabbri M., Liu Z.F., Heaphy C.E.A., Callegari E., Schwind S., Pang J.X., Yu J.H., Muthusamy N., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009;113:6411–6418. [PubMed]
123. Hata K., Okano M., Lei H., Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development. 2002;129:1983–1993. [PubMed]
124. Feltus F.A., Lee E.K., Costello J.F., Plass C., Vertino P.M. Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA. 2003;100:12253–12258. [PubMed]
125. Jair K.W., Bachman K.E., Suzuki H., Ting A.H., Rhee I., Yen R.W.C., Baylin S.B., Schuebel K.E. De novo CpG island methylation in human cancer cells. Cancer Res. 2006;66:682–692. [PubMed]
126. Jia D., Jurkowska R.Z., Zhang X., Jeltsch A., Cheng X.D. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature. 2007;449:248–251. [PMC free article] [PubMed]
127. Ooi S.K.T., Qiu C., Bernstein E., Li K.Q., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature. 2007;448:714–717. [PMC free article] [PubMed]
128. Ferguson-Smith A.C., Greally J.M. Epigenetics: Perceptive enzymes. Nature. 2007;449:148–149. [PubMed]
129. Zhang Y.Y., Rohde C., Tierling S., Jurkowski T.P., Bock C., Santacruz D., Ragozin S., Reinhardt R., Groth M., Walter J., et al. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet. 2009;5 doi: 10.1371/journal.pgen.1000438.. [PMC free article] [PubMed] [Cross Ref]
130. Ooi S.K.T., Bestor T.H. The colorful history of active DNA demethylation. Cell. 2008;133:1145–1148. [PubMed]
131. Hattori N., Imao Y., Nishino K., Ohgane J., Yagi S., Tanaka S., Shiota K. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells. 2007;12:387–396. [PubMed]
132. Simonsson S., Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 2004;6:984–990. [PubMed]
133. La Salle S., Mertineit C., Taketo T., Moens P.B., Bestor T.H., Trasler J.M. Windows for sex-specific methylation marked by DNA methyltransferase expression profiles in mouse germ cells. Dev. Biol. 2004;268:403–415. [PubMed]
134. Lees-Murdock D.J., Shovlin T.C., Gardiner T., De Felici M., Walsh C.P. DNA methyltransferase expression in the mouse germ line during periods of de novo methylation. Dev. Dyn. 2005;232:992–1002. [PubMed]
135. Davis T.L., Yang G.J., McCarrey J.R., Bartolomei M.S. The H19 methylation imprint is erased and re-established differentially on the parental alleles during male germ cell development. Hum. Mol. Genet. 2000;9:2885–2894. [PubMed]
136. Fedoriw A.M., Stein P., Svoboda P., Schultz R.M., Bartolomei M.S. Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting. Science. 2004;303:238–240. [PubMed]
137. Jelinic P., Stehle J.C., Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol. 2006;4:e355. [PMC free article] [PubMed]
138. Verona R.I., Mann M.R.W., Bartolomei M.S. Genomic imprinting: Intricacies of epigenetic regulation in clusters. Annu. Rev. Cell Dev. Biol. 2003;19:237–259. [PubMed]
139. Fitzpatrick G.V., Soloway P.D., Higgins M.J. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat. Genet. 2002;32:426–431. [PubMed]
140. Mancini-DiNardo D., Steele S.J.S., Ingram R.S., Tilghman S.M. A differentially methylated region within the gene KCNQ1 functions as an imprinted promoter and silencer. Hum. Mol. Genet. 2003;12:283–294. [PubMed]
141. Thorvaldsen J.L., Duran K.L., Bartolomei M.S. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and IGF2. Genes Dev. 1998;12:3693–3702. [PubMed]
142. Zhang Y.J., Qu L.H. Non-coding RNAs and the acquisition of genomic imprinting in mammals. Sci. China C Life Sci. 2009;52:195–204. [PubMed]
143. Peters J., Robson J.E. Imprinted noncoding RNAs. Mamm. Genome. 2008;19:493–502. [PubMed]
144. Latos P.A., Barlow D.P. Regulation of imprinted expression by macro non-coding RNAs. RNA Biol. 2009;6:100–106. [PMC free article] [PubMed]
145. Bourc’his D., Voinnet O. A small-RNA perspective on gametogenesis, fertilization, and early zygotic development. Science. 2010;330:617–622. [PubMed]
146. Moazed D. Small RNAs in transcriptional gene silencing and genome defence. Nature. 2009;457:413–420. [PMC free article] [PubMed]
147. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs. Cell. 2007;129:1311–1323. [PMC free article] [PubMed]
148. Koerner M.V., Pauler F.M., Huang R., Barlow D.P. The function of non-coding RNAs in genomic imprinting. Development. 2009;136:1771–1783. [PMC free article] [PubMed]
149. Erhard F., Zimmer R. Classification of ncRNAs using position and size information in deep sequencing data. Bioinformatics. 2010;26:i426–i432. [PMC free article] [PubMed]
150. Childs L., Nikoloski Z., May P., Walther D. Identification and classification of ncRNA molecules using graph properties. Nucleic Acids Res. 2009;37 doi: 10.1093/nar/gkp206.. [PMC free article] [PubMed] [Cross Ref]
151. Wutz A., Gribnau J. X inactivation Xplained. Curr. Opin. Genet. Dev. 2007;17:387–393. [PubMed]
152. Seitz H., Royo H., Lin S.P., Youngson N., Ferguson-Smith A.C., Cavaille J. Imprinted small RNA genes. Biol. Chem. 2004;385:905–911. [PubMed]
153. Royo H., Bortolin M.L., Seitz H., Cavaille J. Small non-coding RNAs and genomic imprinting. Cytogenet. Genome Res. 2006;113:99–108. [PubMed]
154. Wang Y., Medvid R., Melton C., Jaenisch R., Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 2007;39:380–385. [PMC free article] [PubMed]
155. Kanellopoulou C., Muljo S.A., Kung A.L., Ganesan S., Drapkin R., Jenuwein T., Livingston D.M., Rajewsky K. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 2005;19:489–501. [PubMed]
156. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008;9:219–230. [PubMed]
157. Santoro F., Barlow D.P. Developmental control of imprinted expression by macro non-coding RNAs. Semin. Cell Dev. Biol. 2011;22:328–335. [PubMed]
158. Martello G., Zacchigna L., Inui M., Montagner M., Adorno M., Mamidi A., Morsut L., Soligo S., Tran U., Dupont S., et al. MicroRNA control of nodal signalling. Nature. 2007;449:183–188. [PubMed]
159. Kwon C., Han Z., Olson E.N., Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates notch signaling. Proc. Natl. Acad. Sci. USA. 2005;102:18986–18991. [PubMed]
160. Deng Z., Chen J.-F., Wang D.-Z. Transgenic overexpression of miR-133a in skeletal muscle. BMC Musculoskelet. Disord. 2011;12 doi: 10.1186/1471-2474-12-115.. [PMC free article] [PubMed] [Cross Ref]
161. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5:R13–R23. [PMC free article] [PubMed]
162. Vo N.K., Cambronne X.A., Goodman R.H. MicroRNA pathways in neural development and plasticity. Curr. Opin. Neurobiol. 2010;20:457–465. [PubMed]
163. Hudson Q.J., Kulinski T.M., Huetter S.P., Barlow D.P. Genomic imprinting mechanisms in embryonic and extraembryonic mouse tissues. Heredity. 2010;105:45–56. [PMC free article] [PubMed]
164. Lewis A., Mitsuyaj K., Constancia M., Reik W. Tandem repeat hypothesis in imprinting: Deletion of a conserved direct repeat element upstream of H19 has no effect on imprinting in the IGF2-H19 region. Mol. Cell. Biol. 2004;24:5650–5656. [PMC free article] [PubMed]
165. Umlauf D., Goto Y., Cao R., Cerqueira F., Wagschal A., Zhang Y., Feil R. Imprinting along the KCNQ1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat. Genet. 2004;36:1296–1300. [PubMed]
166. Pandey R.R., Mondal T., Mohammad F., Enroth S., Redrup L., Komorowski J., Nagano T., Mancini-DiNardo D., Kanduri C. Antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell. 2008;32:232–246. [PubMed]
167. Terranova R., Yokobayashi S., Stadler M.B., Otte A.P., van Lohuizen M., Orkin S.H., Peters A.H.F.M. Polycomb group proteins EZH2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev. Cell. 2008;15:668–679. [PubMed]
168. Carmell M.A., Hannon G.J. RNase III enzymes and the initiation of gene silencing. Nat. Struct. Mol. Biol. 2004;11:214–218. [PubMed]
169. Chu C.-Y., Rana T.M. Small RNAs: Regulators and guardians of the genome. J. Cell. Physiol. 2007;213:412–419. [PubMed]
170. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 2008;9:102–114. [PubMed]
171. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009;10:126–139. [PubMed]
172. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–1414. [PMC free article] [PubMed]
173. Girard A., Sachidanandam R., Hannon G.J., Carmell M.A. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature. 2006;442:199–202. [PubMed]
174. Klattenhoff C., Theurkauf W. Biogenesis and germline functions of piRNAs. Development. 2008;135:3–9. [PubMed]
175. Szakmary A., Cox D.N., Wang Z., Lin H.F. Regulatory relationship among piwi, pumilio, and bag-of-marbles in Drosophila germline stem cell self-renewal and differentiation. Curr. Biol. 2005;15:171–178. [PubMed]
176. Efroni S., Duttagupta R., Cheng J., Dehghani H., Hoeppner D.J., Dash C., Bazett-Jones D.P., Le Grice S., McKay R.D.G., Buetow K.H., et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–447. [PMC free article] [PubMed]
177. Kimura H., Tada M., Nakatsuji N., Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell. Biol. 2004;24:5710–5720. [PMC free article] [PubMed]
178. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. [PubMed]
179. Kim J.M., Liu H.L., Tazaki M., Nagata M., Aoki F. Changes in histone acetylation during mouse oocyte meiosis. J. Cell Biol. 2003;162:37–46. [PMC free article] [PubMed]
180. Kimmins S., Sassone-Corsi P. Chromatin remodelling and epigenetic features of germ cells. Nature. 2005;434:583–589. [PubMed]
181. Yamanaka K., Sugimura S., Wakai T., Kawahara M., Sato E. Acetylation level of histone H3 in early embryonic stages affects subsequent development of miniature pig somatic cell nuclear transfer embryos. J. Reprod. Dev. 2009;55:638–644. [PubMed]
182. Zhang Y.H., Li J., Villemoes K., Pedersen A.M., Purup S., Vajta G. An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. Cloning Stem Cells. 2007;9:357–363. [PubMed]
183. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., Weng Z.P., Snyder M., Dermitzakis E.T., Thurman R.E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799–816. [PMC free article] [PubMed]
184. Tamaru H., Selker E.U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature. 2001;414:277–283. [PubMed]
185. Jackson J.P., Lindroth A.M., Cao X.F., Jacobsen S.E. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature. 2002;416:556–560. [PubMed]
186. Fuks F. DNA methylation and histone modifications: Teaming up to silence genes. Curr. Opin. Genet. Dev. 2005;15:490–495. [PubMed]
187. Francis N.J., Follmer N.E., Simon M.D., Aghia G., Butler J.D. Polycomb proteins remain bound to chromatin and DNA during DNA replication in vitro. Cell. 2009;137:110–122. [PMC free article] [PubMed]
188. Blobel G.A., Kadauke S., Wang E., Lau A.W., Zuber J., Chou M.M., Vakoc C.R. A reconfigured pattern of Mll occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol. Cell. 2009;36:970–983. [PMC free article] [PubMed]
189. Hahn M.A., Wu X.W., Li A.X., Hahn T., Pfeifer G.P. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS One. 2011;6 doi: 10.1371/journal.pone.0018844.. [PMC free article] [PubMed] [Cross Ref]
190. Bartke T., Vermeulen M., Xhemalce B., Robson S.C., Mann M., Kouzarides T. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell. 2010;143:470–484. [PMC free article] [PubMed]
191. Lindroth A.M., Park Y.J., McLean C.M., Dokshin G.A., Persson J.M., Herman H., Pasini D., Miro X., Donohoe M.E., Lee J.T., et al. Antagonism between DNA and H3K27 methylation at the imprinted RASGRF1 locus. PLoS Genet. 2008;4 doi: 10.1371/journal.pgen.1000145.. [PMC free article] [PubMed] [Cross Ref]
192. Myant K., Termanis A., Sundaram A.Y.M., Boe T., Li C., Merusi C., Burrage J., de Las Heras J.I., Stancheva I. LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res. 2011;21:83–94. [PubMed]
193. Fournier C., Goto Y.J., Ballestar E., Delaval K., Hever A.M., Esteller M., Feil R. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J. 2002;21:6560–6570. [PubMed]
194. Rougeulle C., Navarro P., Avner P. Promoter-restricted H3 Lys 4 di-methylation is an epigenetic mark for monoallelic expression. Hum. Mol. Genet. 2003;12:3343–3348. [PubMed]
195. Appanah R., Dickerson D.R., Goyal P., Groudine M., Lorincz M.C. An unmethylated 3′ promoter-proximal region is required for efficient transcription initiation. PLoS Genet. 2007;3:241–253. [PMC free article] [PubMed]
196. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 2007;39:457–466. [PubMed]
197. O’Carroll D., Erhardt S., Pagani M., Barton S.C., Surani M.A., Jenuwein T. The Polycomb-group gene EZH2 is required for early mouse development. Mol. Cell. Biol. 2001;21:4330–4336. [PMC free article] [PubMed]
198. Tachibana M., Sugimoto K., Nozaki M., Ueda J., Ohta T., Ohki M., Fukuda M., Takeda N., Niida H., Kato H., et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16:1779–1791. [PubMed]
199. Lagger G., O’Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002;21:2672–2681. [PubMed]
200. Tilghman S.M. The sins of the fathers and mothers: Genomic imprinting in mammalian development. Cell. 1999;96:185–193. [PubMed]
201. Wagschal A., Feil R. Genomic imprinting in the placenta. Cytogenet. Genome Res. 2006;113:90–98. [PubMed]
202. Davies W., Smith R.J., Kelsey G., Wilkinson L.S. Expression patterns of the novel imprinted genes Nap1l5 and Peg13 and their non-imprinted host genes in the adult mouse brain. Gene Expr. Patterns. 2004;4:741–747. [PubMed]
203. Smith R.J., Dean W., Konfortova G., Kelsey G. Identification of novel imprinted genes in a genome-wide screen for maternal methylation. Genome Res. 2003;13:558–569. [PubMed]
204. Kagitani F., Kuroiwa Y., Wakana S., Shiroishi T., Miyoshi N., Kobayashi S., Nishida M., Kohda T., KanekoIshino T., Ishino F. Peg5/Neuronatin is an imprinted gene located on sub-distal chromosome 2 in the mouse. Nucleic Acids Res. 1997;25:3428–3432. [PMC free article] [PubMed]
205. Kikyo N., Williamson C.M., John R.M., Barton S.C., Beechey C.V., Ball S.T., Cattanach B.M., Surani M.A., Peters J. Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2. Dev. Biol. 1997;190:66–77. [PubMed]
206. Choi J.D., Underkoffler L.A., Wood A.J., Collins J.N., Williams P.T., Golden J.A., Schuster E.F., Loomes K.M., Oakey R.J. A novel variant of Inpp5f is imprinted in brain, and its expression is correlated with differential methylation of an internal CpG island. Mol. Cell. Biol. 2005;25:5514–5522. [PMC free article] [PubMed]
207. Peters J., Beechey C. Identification and characterisation of imprinted genes in the mouse. Brief. Funct. Genomics Proteomics. 2004;2:320–333. [PubMed]
208. Branco M.R., Oda M., Reik W. Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis. Genes Dev. 2008;22:1567–1571. [PubMed]
209. Ikegami K., Ohgane J., Tanaka S., Yagi S., Shiota K. Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. Int. J. Dev. Biol. 2009;53:203–214. [PubMed]
210. Royo H., Cavaille J. Non-coding RNAs in imprinted gene clusters. Biol. Cell. 2008;100:149–166. [PubMed]
211. Wutz A., Smrzka O.W., Schweifer N., Schellander K., Wagner E.F., Barlow D.P. Imprinted expression of the IGF2r gene depends on an intronic CpG island. Nature. 1997;389:745–749. [PubMed]
212. Birger Y., Shemer R., Perk J., Razin A. The imprinting box of the mouse IGF2r gene. Nature. 1999;397:84–88. [PubMed]
213. Kantor B., Makedonski K., Green-Finberg Y., Shemer R., Razin A. Control elements within the PWS/AS imprinting box and their function in the imprinting process. Hum. Mol. Genet. 2004;13:751–762. [PubMed]
214. Ideraabdullah F.Y., Abramowitz L.K., Thorvaldsen J.L., Krapp C., Wen S.C., Engel N., Bartolomei M.S. Novel cis-regulatory function in ICR-mediated imprinted repression of H19. Dev. Biol. 2011;355:349–357. [PMC free article] [PubMed]
215. Edwards C.A., Ferguson-Smith A.C. Mechanisms regulating imprinted genes in clusters. Curr. Opin. Cell Biol. 2007;19:281–289. [PubMed]
216. Brandeis M., Kafri T., Ariel M., Chaillet J.R., McCarrey J., Razin A., Cedar H. The ontogeny of allele-specific methylation associated with imprinted genes in the mouse. EMBO J. 1993;12:3669–3677. [PubMed]
217. Moore T., Constancia M., Zubair M., Bailleul B., Feil R., Sasaki H., Reik W. Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse IGF2. Proc. Natl. Acad. Sci. USA. 1997;94:12509–12514. [PubMed]
218. Feil R., Walter J., Allen N.D., Reik W. Developmental control of allelic methylation in the imprinted mouse IGF2 and H19 genes. Development. 1994;120:2933–2943. [PubMed]
219. Kacem S., Feil R. Chromatin mechanisms in genomic imprinting. Mamm. Genome. 2009;20:544–556. [PubMed]
220. Hirasawa R., Chiba H., Kaneda M., Tajima S., Li E., Jaenisch R., Sasaki H. Maternal and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during preimplantation development. Genes Dev. 2008;22:1607–1616. [PubMed]
221. Yang L., Chavatte-Palmer P., Kubota C., O’Neill M., Hoagland T., Renard J.P., Taneja M., Yang X.Z., Tian X.C. Expression of imprinted genes is aberrant in deceased newborn cloned calves and relatively normal in surviving adult clones. Mol. Reprod. Dev. 2005;71:431–438. [PubMed]
222. Zhang S.Q., Kubota C., Yang L., Zhang Y.Q., Page R., O’Neill M., Yang X.Z., Tian X.C. Genomic imprinting of H19 in naturally reproduced and cloned cattle. Biol. Reprod. 2004;71:1540–1544. [PubMed]
223. Sato A., Otsu E., Negishi H., Utsunomiya T., Arima T. Aberrant DNA methylation of imprinted loci in superovulated oocytes. Hum. Reprod. 2007;22:26–35. [PubMed]
224. Market-Velker B.A., Zhang L.Y., Magri L.S., Bonvissuto A.C., Mann M.R.W. Dual effects of superovulation: Loss of maternal and paternal imprinted methylation in a dose-dependent manner. Hum. Mol. Genet. 2010;19:36–51. [PubMed]
225. Park C.H., Kim H.S., Lee S.G., Lee C.K. Methylation status of differentially methylated regions at IGF2/H19 locus in porcine gametes and preimplantation embryos. Genomics. 2009;93:179–186. [PubMed]
226. Suzuki J., Therrien J., Filion F., Lefebvre R., Goff A.K., Perecin F., Meirelles F.V., Smith L.C. Loss of methylation at H19 DMD is associated with biallelic expression and reduced development in cattle derived by somatic cell nuclear transfer. Biol. Reprod. 2011;84:947–956. [PubMed]
227. Morgan H.D., Santos F., Green K., Dean W., Reik W. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 2005;14:R47–R58. [PubMed]
228. Sassone-Corsi P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science. 2002;296:2176–2178. [PubMed]
229. Pathak S., Kedia-Mokashi N., Saxena M., D’Souza R., Maitra A., Parte P., Gill-Sharma M., Balasinor N. Effect of tamoxifen treatment on global and insulin-like growth factor 2-H19 locus-specific DNA methylation in rat spermatozoa and its association with embryo loss. Fertil. Steril. 2009;91:2253–2263. [PubMed]
230. Delaval K., Feil R. Epigenetic regulation of mammalian genomic imprinting. Curr. Opin. Genet. Dev. 2004;14:188–195. [PubMed]
231. McLay D.W., Clarke H.J. Remodelling the paternal chromatin at fertilization in mammals. Reproduction. 2003;125:625–633. [PubMed]
232. Labosky P.A., Barlow D.P., Hogan B.L.M. Mouse embryonic germ (EG) cell-lines: Transmission through the germline and differences in the methylation imprint of insulin-like growth-factor 2 receptor (IGF2r) gene compared with embryonic stem (ES) cell-lines. Development. 1994;120:3197–3204. [PubMed]
233. Tada T., Tada M., Hilton K., Barton S.C., Sado T., Takagi N., Surani M.A. Epigenotype switching of imprintable loci in embryonic germ cells. Dev. Genes Evol. 1998;207:551–561. [PubMed]
234. Durcova-Hills G., Burgoyne P., McLaren A. Analysis of sex differences in EGC imprinting. Dev. Biol. 2004;268:105–110. [PubMed]
235. Aravin A.A., Sachidanandam R., Bourc’his D., Schaefer C., Pezic D., Toth K.F., Bestor T., Hannon G.J. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol. Cell. 2008;31:785–799. [PMC free article] [PubMed]
236. Carmell M.A., Girard A., van de Kant H.J.G., Bourc’his D., Bestor T.H., de Rooij D.G., Hannon G.J. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell. 2007;12:503–514. [PubMed]
237. Kuramochi-Miyagawa S., Watanabe T., Gotoh K., Totoki Y., Toyoda A., Ikawa M., Asada N., Kojima K., Yamaguchi Y., Ijiri T.W., et al. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev. 2008;22:908–917. [PubMed]
238. Nicholas C.R., Chavez S.L., Baker V.L., Pera R.A.R. Instructing an embryonic stem cell-derived oocyte fate: Lessons from endogenous oogenesis. Endocr. Rev. 2009;30:264–283. [PubMed]
239. Watanabe T., Totoki Y., Toyoda A., Kaneda M., Kuramochi-Miyagawa S., Obata Y., Chiba H., Kohara Y., Kono T., Nakano T., et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature. 2008;453:539–543. [PubMed]
240. Yoon B.J., Herman H., Sikora A., Smith L.T., Plass C., Soloway P.D. Regulation of DNA methylation of RASGRF1. Nat. Genet. 2002;30:92–96. [PMC free article] [PubMed]
241. Holmes R., Chang Y.J., Soloway P.D. Timing and sequence requirements defined for embryonic maintenance of imprinted DNA methylation at RASGRF1. Mol. Cell. Biol. 2006;26:9564–9570. [PMC free article] [PubMed]
242. Constancia M., Hemberger M., Hughes J., Dean W., Ferguson-Smith A., Fundele R., Stewart F., Kelsey G., Fowden A., Sibley C., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature. 2002;417:945–948. [PubMed]
243. Kalscheuer V.M., Mariman E.C., Schepens M.T., Rehder H., Ropers H.H. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat. Genet. 1993;5:74–78. [PubMed]
244. Gardner D.K., Larman M.G., Thouas G.A. Sex-related physiology of the preimplantation embryo. Mol. Hum. Reprod. 2010;16:539–547. [PubMed]
245. Biliya S., Bulla L.A. Genomic imprinting: The influence of differential methylation in the two sexes. Exp. Biol. Med. 2010;235:139–147. [PubMed]
246. Hajkova P., Erhardt S., Lane N., Haaf T., El-Maarri O., Reik W., Walter J., Surani M.A. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 2002;117:15–23. [PubMed]
247. Yamazaki Y., Mann M.R.W., Lee S.S., Marh J., McCarrey J.R., Yanagimachi R., Bartolomei M.S. Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc. Natl. Acad. Sci. USA. 2003;100:12207–12212. [PubMed]
248. Hajkova P., Ancelin K., Waldmann T., Lacoste N., Lange U.C., Cesari F., Lee C., Almouzni G., Schneider R., Surani M.A. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature. 2008;452:877–881. [PMC free article] [PubMed]
249. Hazzouri M., Pivot-Pajot C., Faure A.K., Usson Y., Pelletier R., Sele B., Khochbin S., Rousseaux S. Regulated hyperacetylation of core histones during mouse spermatogenesis: Involvement of histone-deacetylases. Eur. J. Cell Biol. 2000;79:950–960. [PubMed]
250. Szabo P.E., Mann J.R. Biallelic expression of imprinted genes in the mouse germ-line: Implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Dev. 1995;9:1857–1868. [PubMed]
251. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–353. [PubMed]
252. Ku M., Koche R.P., Rheinbay E., Mendenhall E.M., Endoh M., Mikkelsen T.S., Presser A., Nusbaum C., Xie X.H., Chi A.S., et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 2008;4 doi: 10.1371/journal.pgen.1000242.. [PMC free article] [PubMed] [Cross Ref]
253. Kashyap V., Rezende N.C., Scotland K.B., Shaffer S.M., Persson J.L., Gudas L.J., Mongan N.P. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 2009;18:1093–1108. [PMC free article] [PubMed]
254. Atkinson S., Armstrong L. Epigenetics in embryonic stem cells: Regulation of pluripotency and differentiation. Cell Tissue Res. 2008;331:23–29. [PubMed]
255. Pasini D., Bracken A.P., Hansen J.B., Capillo M., Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell. Biol. 2007;27:3769–3779. [PMC free article] [PubMed]
256. Herranz N., Pasini D., Diaz V.M., Franci C., Gutierrez A., Dave N., Escriva M., Hernandez-Munoz I., di Croce L., Helin K., et al. Polycomb complex 2 is required for E-cadherin repression by the snail1 transcription factor. Mol. Cell. Biol. 2008;28:4772–4781. [PMC free article] [PubMed]
257. Yuzyuk T., Fakhouri T.H.I., Kiefer J., Mango S.E. The polycomb complex protein mes-2/E(z) promotes the transition from developmental plasticity to differentiation in C. elegans embryos. Dev. Cell. 2009;16:699–710. [PMC free article] [PubMed]
258. Iwahashi K., Yoshioka H., Low E.W., McCarrey J.R., Yanagimachi R., Yamazaki Y. Autonomous regulation of sex-specific developmental programming in mouse fetal germ cells. Biol. Reprod. 2007;77:697–706. [PubMed]
259. Feil R., Berger F. Convergent evolution of genomic imprinting in plants and mammals. Trends Genet. 2007;23:192–199. [PubMed]
260. Wagschal A., Sutherland H.G., Woodfine K., Henckel A., Chebli K., Schulz R., Oakey R.J., Bickmore W.A., Feil R. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol. Cell. Biol. 2008;28:1104–1113. [PMC free article] [PubMed]
261. Ono R., Kobayashi S., Wagatsuma H., Aisaka K., Kohda T., Kaneko-Ishino T., Ishino F. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics. 2001;73:232–237. [PubMed]
262. Sekita Y., Wagatsuma H., Nakamura K., Ono R., Kagami M., Wakisaka N., Hino T., Suzuki-Migishima R., Kohda T., Ogura A., et al. Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat. Genet. 2008;40:243–248. [PubMed]
263. Haycock P.C., Ramsay M. Exposure of mouse embryos to ethanol during preimplantation development: Effect on dna methylation in the H19 imprinting control region. Biol. Reprod. 2009;81:618–627. [PubMed]
264. Su J.M., Xu W.B., Li Y.Y., Wang L.J., Wang Y.S., Zhang Y. The methylation status of PEG10 in placentas of cloned transgenic calves. Yi Chuan. 2011;33:533–538. [PubMed]
265. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., van Eynde A., Bernard D., Vanderwinden J.M., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439:871–874. [PubMed]
266. Pasini D., Bracken A.P., Agger K., Christensen J., Hansen K., Cloos P.A.C., Helin K. Regulation of Stem Cell Differentiation by Histone Methyltransferases and Demethylases. Cold Spring Harb. Symp. Quant. Biol. 2008;73:253–263. [PubMed]
267. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell. 2007;128:735–745. [PubMed]
268. Bantignies F., Cavalli G. Cellular memory and dynamic regulation of polycomb group proteins. Curr. Opin. Cell Biol. 2006;18:275–283. [PubMed]
269. Ross P.J., Ragina N.P., Rodriguez R.M., Iager A.E., Siripattarapravat K., Lopez-Corrales N., Cibelli J.B. Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development. Reproduction. 2008;136:777–785. [PubMed]
270. Dunn K.L., Davie J.R. The many roles of the transcriptional regulator CTCF. Biochem. Cell Biol. 2003;81:161–167. [PubMed]
271. Filippova G.N., Fagerlie S., Klenova E.M., Myers C., Dehner Y., Goodwin G., Neiman P.E., Collins S.J., Lobanenkov V.V. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-Myc oncogenes. Mol. Cell. Biol. 1996;16:2802–2813. [PMC free article] [PubMed]
272. Soshnikova N., Montavon T., Leleu M., Galjart N., Duboule D. Functional analysis of CTCF during mammalian limb development. Dev. Cell. 2010;19:819–830. [PubMed]
273. Essien K., Vigneau S., Apreleva S., Singh L.N., Bartolomei M.S., Hannenhalli S. CTCF binding site classes exhibit distinct evolutionary, genomic, epigenomic and transcriptomic features. Genome Biol. 2009;10 doi: 10.1186/gb-2009-10-11-r131.. [PMC free article] [PubMed] [Cross Ref]
274. Vostrov A.A., Quitschke W.W. The zinc finger protein CTCF binds to the APBβ domain of the amyloid β-protein precursor promoter. J. Biol. Chem. 1997;272:33353–33359. [PubMed]
275. Cuddapah S., Jothi R., Schones D.E., Roh T.Y., Cui K.R., Zhao K.J. Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res. 2009;19:24–32. [PubMed]
276. Phillips J.E., Corces V.G. CTCF: Master weaver of the genome. Cell. 2009;137:1194–1211. [PMC free article] [PubMed]
277. Han L., Lee D.H., Szabo P.E. CTCF is the master organizer of domain-wide allele-specific chromatin at the H19/IGF2 imprinted region. Mol. Cell. Biol. 2008;28:1124–1135. [PMC free article] [PubMed]
278. Kim T.H., Abdullaev Z.K., Smith A.D., Ching K.A., Loukinov D.I., Green R.D., Zhang M.Q., Lobanenkov V.V., Ren B. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell. 2007;128:1231–1245. [PMC free article] [PubMed]
279. Ideraabdullah F.Y., Vigneau S., Bartolomei M.S. Genomic imprinting mechanisms in mammals. Mutat. Res. 2008;647:77–85. [PMC free article] [PubMed]
280. Matsuzaki H., Okamura E., Fukamizu A., Tanimoto K. CTCF binding is not the epigenetic mark that establishes post-fertilization methylation imprinting in the transgenic H19 ICR. Hum. Mol. Genet. 2010;19:1190–1198. [PubMed]
281. Esteve P.-O., Chin H.G., Smallwood A., Feehery G.R., Gangisetty O., Karpf A.R., Carey M.F., Pradhan S. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006;20:3089–3103. [PubMed]
282. Robertson A.K., Geiman T.M., Sankpal U.T., Hager G.L., Robertson K.D. Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro. Biochem. Biophys. Res. Commun. 2004;322:110–118. [PubMed]
Articles from International Journal of Molecular Sciences are provided here courtesy of
Multidisciplinary Digital Publishing Institute (MDPI)